Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - FLYNN JAMES E
Last Updated 
8-Aug-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

FLYNN JAMES E: Declared Holdings
Company/RelationshipReportedShares  Ownership
Alimera Sciences, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ALIM
(historical quotes, profile, other insiders)
8-Dec-155,878,015  Indirect
Antares Pharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:ATRS
(historical quotes, profile, other insiders)
30-Sep-1515,451,126  Indirect
AveXis, Inc.
Director
NasdaqGS:AVXS
(historical quotes, profile, other insiders)
17-Feb-162,236,700  Indirect
AxoGen, Inc.
Beneficial Owner (10% or more)
NasdaqCM:AXGN
(historical quotes, profile, other insiders)
21-Jul-163,000,000  Indirect
Audentes Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:BOLD
(historical quotes, profile, other insiders)
25-Jul-161,403,654  Indirect
CAS Medical Systems, Inc.
Beneficial Owner (10% or more)
NasdaqCM:CASM
(historical quotes, profile, other insiders)
1-Jan-153,200,000  Indirect
CytomX Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGS:CTMX
(historical quotes, profile, other insiders)
14-Oct-15946,024  Indirect
Dicerna Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DRNA
(historical quotes, profile, other insiders)
25-Nov-141,774,662  Indirect
Editas Medicine, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EDIT
(historical quotes, profile, other insiders)
8-Feb-161,809,400  Indirect
eHealth, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EHTH
(historical quotes, profile, other insiders)
21-Jun-162,640,609  Indirect
aTyr Pharma, Inc.
Beneficial Owner (10% or more)
NasdaqGS:LIFE
(historical quotes, profile, other insiders)
12-May-15511,528  Indirect
Neos Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:NEOS
(historical quotes, profile, other insiders)
28-Jul-15858,332  Indirect
Nivalis Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:NVLS
(historical quotes, profile, other insiders)
23-Jun-153,732,412  Indirect
Invitae Corporation Common Stoc
Beneficial Owner (10% or more)
NYSE:NVTA
(historical quotes, profile, other insiders)
18-Feb-15341,666  Indirect
Proteon Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:PRTO
(historical quotes, profile, other insiders)
27-Oct-141,255,107  Indirect
REGENXBIO Inc.
Beneficial Owner (10% or more)
NasdaqGS:RGNX
(historical quotes, profile, other insiders)
22-Sep-151,344,042  Indirect
SteadyMed Ltd.
Beneficial Owner (10% or more)
NasdaqGM:STDY
(historical quotes, profile, other insiders)
25-Mar-151,267,733  Indirect
Streamline Health Solutions, In
Beneficial Owner (10% or more)
NasdaqCM:STRM
(historical quotes, profile, other insiders)
17-Dec-151,875,500  Indirect
Syros Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:SYRS
(historical quotes, profile, other insiders)
6-Jul-162,095,220  Indirect
Vanda Pharmaceuticals Inc.
Beneficial Owner (10% or more)
NasdaqGM:VNDA
(historical quotes, profile, other insiders)
16-Dec-155,996,691  Indirect
XenoPort, Inc.
Beneficial Owner (10% or more)
NasdaqGS:XNPT
(historical quotes, other insiders)
19-Feb-1611,572,125  Indirect
Zafgen, Inc.
Beneficial Owner (10% or more)
NasdaqGS:ZFGN
(historical quotes, profile, other insiders)
20-Jul-161,714,104  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
25-Jul-16 *1,003,654BOLD Acquisition (Non Open Market)
25-Jul-16 *400,000BOLD Purchase at $15 per share.
(Cost of $6,000,000)
21-Jul-16 *102,136AXGN Sale at $6.70 per share.
(Proceeds of $684,311)
20-Jul-16 *1,341,499ZFGN Sale at $3.31 per share.
(Proceeds of $4,440,361)
18-Jul-16 *41,425AXGN Sale at $6.87 per share.
(Proceeds of $284,589)
15-Jul-16 *31,788AXGN Sale at $7.32 per share.
(Proceeds of $232,688)
14-Jul-16 *206,090AXGN Sale at $7.70 per share.
(Proceeds of $1,586,893)
6-Jul-16 *1,695,220SYRS Acquisition (Non Open Market)
6-Jul-16 *400,000SYRS Purchase at $12.50 per share.
(Cost of $5,000,000)
21-Jun-16 *26,400EHTH Sale at $14.30 per share.
(Proceeds of $377,520)
20-Jun-16 *178,454EHTH Sale at $14.20 per share.
(Proceeds of $2,534,046)
14-Jun-16 *43,300EHTH Sale at $13.88 per share.
(Proceeds of $601,004)
8-Jun-16 *28,080EHTH Sale at $13.84 per share.
(Proceeds of $388,627)
7-Jun-16 *7,154EHTH Sale at $13.89 per share.
(Proceeds of $99,369)
6-Jun-16 *28,502EHTH Sale at $14 per share.
(Proceeds of $399,028)
2-Jun-16 *42,668EHTH Sale at $13.87 per share.
(Proceeds of $591,805)
1-Jun-16 *5EHTH Sale at $13.80 per share.
(Proceeds of $69)
31-May-16 *56,835EHTH Sale at $13.84 per share.
(Proceeds of $786,596)
27-May-16 *72,649EHTH Sale at $14 per share.
(Proceeds of $1,017,086)
26-May-16 *93,965EHTH Sale at $14.16 per share.
(Proceeds of $1,330,544)
25-May-16 *45,967EHTH Sale at $14.25 per share.
(Proceeds of $655,029)
19-Feb-16 *20,973XNPT Purchase at $3.99 - $3.99 per share.
(Cost of about $84,000)
17-Feb-16 *1,486,383AVXS Acquisition (Non Open Market)
17-Feb-16 *486,495AVXS Purchase at $20 - $20 per share.
(Cost of about $9,730,000)
12-Feb-16 *35,224XNPT Purchase at $3.92 - $3.92 per share.
(Cost of about $138,000)
12-Feb-16 *64,545ZFGN Purchase at $6.25 per share.
(Cost of $403,406)
11-Feb-16 *4,848,537XNPT Purchase at $3.76 - $3.96 per share.
(Cost of about $18,715,000)
11-Feb-16 *2,344ZFGN Purchase at $6.19 - $6.19 per share.
(Cost of about $15,000)
10-Feb-16 *263,822AVXS Statement of Ownership
10-Feb-16 *151,226ZFGN Purchase at $6.23 - $6.23 per share.
(Cost of about $942,000)
9-Feb-16 *2,723,565ZFGN Statement of Ownership
9-Feb-16 *113,923ZFGN Purchase at $5.73 - $5.73 per share.
(Cost of about $653,000)
8-Feb-16 *100,000EDIT Purchase at $16 - $16 per share.
(Cost of about $1,600,000)
8-Feb-16 *1,709,400EDIT Acquisition (Non Open Market)
20-Jan-16 *6,320,974XNPT Statement of Ownership
20-Jan-16 *346,417XNPT Purchase at $4.09 - $4.09 per share.
(Cost of about $1,417,000)
17-Dec-15 *226,000STRM Sale at $1.20 - $1.2 per share.
(Proceeds of about $271,000)
16-Dec-15 *116,464STRM Sale at $1.23 - $1.23 per share.
(Proceeds of about $143,000)
16-Dec-15 *11,170VNDA Purchase at $8.97 - $8.97 per share.
(Cost of about $100,000)
15-Dec-15 *54,795STRM Sale at $1.34 - $1.34 per share.
(Proceeds of about $73,000)
11-Dec-15 *322,872VNDA Purchase at $8.61 - $8.61 per share.
(Cost of about $2,780,000)
10-Dec-15 *103,110VNDA Purchase at $8.59 - $8.59 per share.
(Cost of about $886,000)
9-Dec-15 *775,382VNDA Purchase at $8.21 - $9 per share.
(Cost of about $6,672,000)
8-Dec-15 *55,059ALIM Purchase at $3.04 - $3.04 per share.
(Cost of about $167,000)
7-Dec-15 *136,588ALIM Purchase at $3 - $3 per share.
(Cost of about $410,000)
4-Dec-15 *80,602ALIM Purchase at $3.01 - $3.01 per share.
(Cost of about $243,000)
3-Dec-15 *106,973ALIM Purchase at $3 - $3 per share.
(Cost of about $321,000)
2-Dec-15 *110,514ALIM Purchase at $2.98 - $2.98 per share.
(Cost of about $329,000)
1-Dec-15 *25,765ALIM Purchase at $3.05 - $3.05 per share.
(Cost of about $79,000)
6-Nov-15 *73,250ALIM Purchase at $2.98 - $2.98 per share.
(Cost of about $218,000)
30-Oct-15 *16,542ALIM Purchase at $3 - $3 per share.
(Cost of about $50,000)
28-Oct-15 *26,330ALIM Purchase at $2.99 - $2.99 per share.
(Cost of about $79,000)
27-Oct-15 *33,012ALIM Purchase at $3 - $3 per share.
(Cost of about $99,000)
26-Oct-15 *34,233ALIM Purchase at $3 - $3 per share.
(Cost of about $103,000)
23-Oct-15 *24,181ALIM Purchase at $3 - $3 per share.
(Cost of about $73,000)
22-Oct-15 *1,950ALIM Purchase at $3 - $3 per share.
(Cost of about $5,850)
21-Oct-15 *160,684ALIM Purchase at $3 - $3 per share.
(Cost of about $482,000)
20-Oct-15 *100,130ALIM Purchase at $3 - $3 per share.
(Cost of about $300,000)
19-Oct-15 *129,226ALIM Purchase at $2.92 - $2.92 per share.
(Cost of about $377,000)
14-Oct-15 *321,024CTMX Acquisition (Non Open Market)
14-Oct-15 *625,000CTMX Purchase at $12 - $12 per share.
(Cost of about $7,500,000)
9-Oct-15 *143,080ALIM Purchase at $2.53 - $2.53 per share.
(Cost of about $362,000)
8-Oct-15 *39,633ALIM Purchase at $2.50 - $2.5 per share.
(Cost of about $99,000)
7-Oct-15 *139,072ALIM Purchase at $2.30 - $2.3 per share.
(Cost of about $320,000)
7-Oct-15 *4,441,191ALIM Statement of Ownership
7-Oct-15 *4,441,191ALIM Statement of Ownership
30-Sep-15 *249,998ATRS Sale at $1.69 - $1.69 per share.
(Proceeds of about $422,000)
29-Sep-15 *225,048ATRS Sale at $1.81 - $1.83 per share.
(Proceeds of about $410,000)
28-Sep-15 *1,353,483ATRS Sale at $1.80 - $1.81 per share.
(Proceeds of about $2,443,000)
22-Sep-15 *175,000RGNX Purchase at $22 - $22 per share.
(Cost of about $3,850,000)
22-Sep-15 *1,169,042RGNX Acquisition (Non Open Market)
18-Sep-15 *345,000AXGN Sale at $5.50 per share.
(Proceeds of $1,897,500)
3-Sep-15 *263,822AVXS Purchase at $18.48 - $18.48 per share.
(Cost of about $4,875,000)
28-Jul-15 *400,000NEOS Purchase at $15 - $15 per share.
(Cost of about $6,000,000)
28-Jul-15 *166,666NEOS Sale at $15 - $15 per share.
(Proceeds of about $2,500,000)
28-Jul-15 *416,666NEOS Acquisition (Non Open Market)
28-Jul-15 *208,332NEOS Option Exercise at $12 - $12 per share.
(Cost of about $2,500,000)
20-Jul-15 *106,024ATRS Sale at $2.11 - $2.14 per share.
(Proceeds of about $225,000)
17-Jul-15 *125,769ATRS Sale at $2.20 - $2.2 per share.
(Proceeds of about $277,000)
10-Jul-15 *2,272,759STRM Statement of Ownership
8-Jul-15 *444,341ATRS Sale at $2.05 - $2.07 per share.
(Proceeds of about $915,000)
7-Jul-15 *198,651ATRS Sale at $2.08 - $2.1 per share.
(Proceeds of about $415,000)
6-Jul-15 *191,513ATRS Sale at $2.12 - $2.12 per share.
(Proceeds of about $406,000)
1-Jul-15 *43,836ATRS Sale at $2.10 - $2.11 per share.
(Proceeds of about $92,000)
30-Jun-15 *608,691ATRS Sale at $2.08 - $2.08 per share.
(Proceeds of about $1,266,000)
29-Jun-15 *60,695ATRS Sale at $2.18 - $2.18 per share.
(Proceeds of about $132,000)
26-Jun-15 *318,534ATRS Sale at $2.24 - $2.25 per share.
(Proceeds of about $715,000)
25-Jun-15 *175,200ATRS Sale at $2.25 - $2.25 per share.
(Proceeds of about $394,000)
24-Jun-15 *263,118ATRS Sale at $2.29 - $2.34 per share.
(Proceeds of about $609,000)
23-Jun-15 *181,862ATRS Sale at $2.35 - $2.35 per share.
(Proceeds of about $427,000)
23-Jun-15 *3,078,394NVLS Acquisition (Non Open Market)
23-Jun-15 *250,000NVLS Purchase at $14 - $14 per share.
(Cost of about $3,500,000)
22-Jun-15 *176,483ATRS Sale at $2.41 - $2.41 per share.
(Proceeds of about $425,000)
19-Jun-15 *141,550ATRS Sale at $2.41 - $2.41 per share.
(Proceeds of about $341,000)
18-Jun-15 *210,701ATRS Sale at $2.48 - $2.48 per share.
(Proceeds of about $523,000)
17-Jun-15 *53,605ATRS Sale at $2.41 - $2.41 per share.
(Proceeds of about $129,000)
16-Jun-15 *214,060ATRS Sale at $2.40 - $2.4 per share.
(Proceeds of about $514,000)
16-Jun-15 *404,022NVLS Statement of Ownership
15-Jun-15 *190,141ATRS Sale at $2.40 - $2.41 per share.
(Proceeds of about $457,000)
12-Jun-15 *218,617ATRS Sale at $2.43 - $2.43 per share.
(Proceeds of about $531,000)
11-Jun-15 *339,272ATRS Sale at $2.47 - $2.48 per share.
(Proceeds of about $840,000)
15-May-15 *4,784,157VNDA Statement of Ownership
12-May-15 *461,528LIFE Acquisition (Non Open Market)
12-May-15 *50,000LIFE Purchase at $14 - $14 per share.
(Cost of about $700,000)
11-May-15 *21,578,318ATRS Statement of Ownership
8-Apr-15 *144,385AXGN Sale at $3.25 - $3.25 per share.
(Proceeds of about $469,000)
25-Mar-15 *737,555STDY Purchase at $8.50 - $8.5 per share.
(Cost of about $6,269,000)
25-Mar-15 *530,178STDY Acquisition (Non Open Market)
6-Mar-15 *30,103EHTH Purchase at $9.52 per share.
(Cost of $286,580)
18-Feb-15 *175,000NVTA Purchase at $16 - $16 per share.
(Cost of about $2,800,000)
18-Feb-15 *166,666NVTA Acquisition (Non Open Market)
10-Feb-15 *3,870,824AXGN Statement of Ownership
14-Jan-15 *1,000,000EHTH Purchase at $19.84 - $20.45 per share.
(Cost of about $20,145,000)
1-Jan-15 *1,443,200CASM Sale at $1.65 - $1.65 per share.
(Proceeds of about $2,381,000)
1-Jan-15 *1,443,200CASM Purchase at $1.65 - $1.65 per share.
(Cost of about $2,381,000)
23-Dec-14 *3,977,773VNDA Statement of Ownership
23-Dec-14 *162,014VNDA Purchase at $14.23 - $14.5 per share.
(Cost of about $2,327,000)
25-Nov-14 *121,965DRNA Sale at $11.50 - $11.5 per share.
(Proceeds of about $1,403,000)
24-Nov-14 *100,000DRNA Sale at $11.54 - $11.55 per share.
(Proceeds of about $1,155,000)
21-Nov-14 *100,000DRNA Sale at $11 - $11 per share.
(Proceeds of about $1,100,000)
7-Nov-14 *214,164DRNA Sale at $9 - $9.33 per share.
(Proceeds of about $1,963,000)
27-Oct-14 *691,713PRTO Purchase at $10 - $10 per share.
(Cost of about $6,917,000)
27-Oct-14 *563,394PRTO Acquisition (Non Open Market)
15-Oct-14 *51,449DRNA Sale at $10.01 - $10.01 per share.
(Proceeds of about $515,000)
14-Oct-14 *36,115DRNA Sale at $11.02 - $11.02 per share.
(Proceeds of about $398,000)
10-Oct-14 *30,214DRNA Sale at $12 - $12.14 per share.
(Proceeds of about $365,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?